Skip to content

Madrigal Pharmaceuticals, Inc. MDGL Accrued interest, net of interest received on maturity of investments

Accrued interest, net of interest received on maturity of investments at other companies

Veradermics
 logo
Veradermics MANE
$161.75K
M&T Bank logo
M&T BankMTB
$62M-1.6%
SiTime Corporation logo
SiTime CorporationSITM
$4.26M+30,314%
General Purpose Acquisition Corp.
 logo
General Purpose Acquisition Corp. GPAC
$1.56K-95.5%
SouthState logo
SouthStateSSB
$6.61M+57.6%
Annaly Capital Management logo
Annaly Capital ManagementNLY
$806.48M-3.6%

Other financials

Income statement

See full
Revenue$311.3M+127%
Gross profit$43.5M
Operating income-$92.7M-16.9%
Net income-$94.4M-28.9%
EPS (diluted)-$3.25-24.5%

Balance sheet

See full
Cash & equivalents$232.2M+23.1%
Total debt$377.3M+187%
Total equity$543.5M-23.5%
Total assets$1.2B+23.1%

Cash flow

See full
Operating cash flow-$167.4M-88.4%
CapEx$3.8M
Free cash flow-$171.3M-92.7%

Valuation

See full
Market cap$11.66B+64.2%
Enterprise value$11.81B+67.5%
P/S10.3×-12.1×

Profitability

See full
Gross margin96.5%
Operating margin-27.7%-12.2pp
Net margin-27.3%-12.0pp
FCF margin-59.8%-29.6pp

Returns & leverage

See full
Return on equity-49.3%-0.8pp
Debt / equity0.7×+0.5×
Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept mdgl:IncreaseDecreaseInAccruedInterestNetOfInterestReceived.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments?
Madrigal Pharmaceuticals, Inc. (MDGL) reported accrued interest, net of interest received on maturity of investments of $1.98M in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments changed year-over-year?
Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments decreased by 30.6% year-over-year, from $2.85M to $1.98M.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments?
Over 3 years (2021 to 2025), Madrigal Pharmaceuticals, Inc.'s accrued interest, net of interest received on maturity of investments has grown at a 96.5% compound annual growth rate (CAGR), from $787K to $5.97M.
What does accrued interest, net of interest received on maturity of investments mean?
The net change in interest owed by the company minus interest income collected from investments.
How do you interpret accrued interest, net of interest received on maturity of investments?
An increase indicates higher interest obligations or deferred interest payments, while a decrease reflects interest settlement or cash collection from investments.
How does accrued interest, net of interest received on maturity of investments compare across companies?
Standard for companies with significant debt structures and investment portfolios.